Authors:
MASSIE B
COUTURE F
LAMOUREUX L
MOSSER DD
GUILBAULT C
JOLICOEUR P
BELANGER F
LANGELIER Y
Citation: B. Massie et al., INDUCIBLE OVEREXPRESSION OF A TOXIC PROTEIN BY AN ADENOVIRUS VECTOR WITH A TETRACYCLINE-REGULATABLE EXPRESSION CASSETTE, Journal of virology, 72(3), 1998, pp. 2289-2296
Authors:
QUIRT I
COUTURE F
PICHETTE R
OLWENY C
WHITE D
KING M
SAWKA C
HUAN S
CLINCH J
LAU C
Citation: I. Quirt et al., THE ROLE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN (EPO) IN REDUCING RED-BLOOD-CELL TRANSFUSIONS AND MAINTAINING QUALITY-OF-LIFE (QOL) IN PATIENTS WITH LYMPHOMA AND SOLID TUMORS RECEIVING CYTOTOXIC CHEMOTHERAPY - RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-TRIAL, Blood, 88(10), 1996, pp. 1378-1378
Citation: F. Couture et al., AN ALTERNATIVE CHOICE FOR THE DRYING VARIABLES LEADING TO A MATHEMATICALLY AND PHYSICALLY WELL DESCRIBED PROBLEM, Drying technology, 13(3), 1995, pp. 519-550
Authors:
COLWILL R
CRUMP M
COUTURE F
DANISH R
STEWART AK
SUTTON DMC
SCOTT JG
SUTCLIFFE SB
BRANDWEIN JM
KEATING A
Citation: R. Colwill et al., MINI-BEAM AS SALVAGE THERAPY FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE BEFORE INTENSIVE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Journal of clinical oncology, 13(2), 1995, pp. 396-402
Authors:
IMRIE KR
PRINCE HM
COUTURE F
BRANDWEIN JM
KEATING A
Citation: Kr. Imrie et al., EFFECT OF ANTIMICROBIAL PROPHYLAXIS ON HEMATOPOIETIC RECOVERY FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION - CIPROFLOXACIN VERSUS COTRIMOXAZOLE, Bone marrow transplantation, 15(2), 1995, pp. 267-270
Citation: F. Sanschagrin et al., PRIMARY STRUCTURE OF OXA-3 AND PHYLOGENY OF OXACILLIN-HYDROLYZING CLASS-D BETA-LACTAMASES, Antimicrobial agents and chemotherapy, 39(4), 1995, pp. 887-893
Authors:
CANTIN G
LESPERANCE B
YELLE L
BELANGER D
CANTIN G
BERGERON M
DESJARDINS L
OUELLET P
DUFRESNE J
BEAUREGARD P
LEPINE M
LACROIX L
COUTURE F
GYGER M
Citation: G. Cantin et al., A PHASE-II, OPEN-LABEL STUDY TO EVALUATE 2 DIFFERENT SCHEDULES FOR INTEGRATING FILGRASTIM (RECOMBINANT-METHIONYL HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR) AS ADJUVANT THERAPY IN THE TREATMENT OF PATIENTS WITH HODGKINS LYMPHOMA RECEIVING MOPP ABV HYBRID CHEMOTHERAPY/, Blood, 86(10), 1995, pp. 197-197
Authors:
IMRIE KR
COUTURE F
TURNER CC
SUTCLIFFE SB
KEATING A
Citation: Kr. Imrie et al., PERIPHERAL NEUROPATHY FOLLOWING HIGH-DOSE ETOPOSIDE AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 13(1), 1994, pp. 77-79
Authors:
SHER GD
COLWILL R
COUTURE F
STEWART K
CRUMP M
KEATING A
Citation: Gd. Sher et al., ESCALATING THE MELPHALAN DOSE IN A REGIMEN INCLUDING HIGH-DOSE ETOPOSIDE FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IS NOT ASSOCIATED WITH ENHANCED TOXICITY, Experimental hematology, 21(8), 1993, pp. 1130-1130
Authors:
CRUMP M
COUTURE F
KOVACS M
SARAGOSA R
MCCRAE J
BRANDWEIN J
HUEBSCH L
BEAUREGARDZOLLINGER L
KEATING A
Citation: M. Crump et al., INTERLEUKIN-3 FOLLOWED BY GM-CSF FOR DELAYED ENGRAFTMENT AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Experimental hematology, 21(3), 1993, pp. 405-410